We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Real-Time PCR Of Oropharyngeal Swabs Diagnoses Pneumonia in Adults

By LabMedica International staff writers
Posted on 13 Dec 2016
A lack of sensitive tests and difficulties obtaining representative samples contribute to the challenge in identifying etiology in pneumonia. More...
Upper respiratory tract swabs can be easily collected and analyzed with real-time polymerase chain reaction (rtPCR).

The microbial etiology of pneumonia often remains undetected despite extensive diagnostic testing. Blood cultures lack sensitivity and obtaining representative lower respiratory tract samples can be challenging. An etiologic diagnosis allows targeted antimicrobial treatment, a matter of increasing importance as resistance rates increase.

Medical scientists at the University of Iceland (Reykjavik, Iceland) prospectively collected oropharyngeal swabs from 239 adults admitted to hospital with pneumonia. Blood cultures were collected, incubated and cultured using standard methods. Urine antigen testing (UAT) for Streptococcus pneumoniae (SP) was performed using a commercially available kit, the BinaxNOW Streptococcus pneumoniae (Alere, Waltham, MA, USA). An oropharyngeal swab sample using sterile rayon tipped swabs, (COPAN Italia, Brescia, Italy) was collected for rtPCR.

The team extracted nucleic acid from 200 μL specimens and rtPCR was performed with an ABI 7900 384-well system (Applied Biosystems, Foster City, CA, USA). The specificity of rtPCR for SP and Haemophilus influenzae (HI) was tested using reference samples containing S. mitis, S. oralis and S. sanguinis, and H. haemolyticus and H. parainfluenzae respectively. No cross-reaction was noted with either comparison. Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of rtPCR for SP and HI were calculated using combined and separate results from sputum (SP and HI) and blood cultures (SP only), and urine antigen analysis (SP only) as a reference “gold standard”.

When the investigators compared the rtPCR with conventional testing for S. pneumoniae in 57 patients with all tests available, this resulted in a sensitivity of 87 %,a specificity of 79 %, PPV equalled 59 % and the NPV was 94 %, and for 67 H. influenzae patients, the sensitivity was, 75 %, specificity 80 %, PPV 45 % and NPV 94 %. When patients with prior antimicrobial exposure were excluded sensitivity improved: 92 % for S. pneumoniae and 80 % for H. influenzae. Receiver operating characteristic curve analysis demonstrated for S. pneumoniae: AUC = 0.65 and for H. influenzae: AUC = 0.86. Using rtPCR SP was identified in 61 (25.5 %) cases and HI in 50 (20.9 %).

The authors concluded that analysis of oropharyngeal swabs using rtPCR proved both reasonably sensitive and specific for diagnosing pneumonia caused by S. pneumoniae and H. influenzae. This method may be a useful diagnostic adjunct to other methods and of special value in patients unable to provide representative lower airway samples. The study was published online on November 7, 2016, in the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:
University of Iceland
Alere
COPAN Italia
Applied Biosystems

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
New
Automated Immunoassay Analyzer
SuperFlex™
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: A large, international study led by City of Hope found that the new, investigational liquid biopsy, called PANXEON, was highly sensitive in detecting stage 1 and 2 pancreatic cancer and had a low rate of false positives. The test was also able to identify high-grade dysplasia, a precancerous condition of the pancreas, potentially enabling intervention before cancer develops. (Photo courtesy of City of Hope)

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection

Pancreatic cancer has the lowest survival rates of any cancer, with only 14% of patients alive five years after diagnosis. The disease is typically discovered after it has spread, and an estimated 90%... Read more

Technology

view channel
Image: Graphical Abstract (Wenjie Zhang, Zeyu Luo, Kaijie Liu, et al. Science Bulletin, 2026. doi:10.1016/j.scib.2026.09.016)

Multimodal AI Framework Aims to Guide Cancer Immunotherapy Decisions

Cancer immunotherapy has reshaped oncology, but heterogeneous responses and immune-related toxicities continue to complicate routine decision-making. Standard biomarkers, including programmed death-ligand... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.